Timothy A Springer - Net Worth and Insider Trading
Timothy A Springer Net Worth
The estimated net worth of Timothy A Springer is at least $1.0 Billion dollars as of 2024-12-27. Timothy A Springer is the Director, 10% Owner of Morphic Holding Inc and owns about 7,418,960 shares of Morphic Holding Inc (MORF) stock worth over $423 Million. Timothy A Springer is the Director, 10% Owner of Tectonic Therapeutic Inc and owns about 4,593,121 shares of Tectonic Therapeutic Inc (TECX) stock worth over $235 Million. Timothy A Springer is also the Director, 10% Owner of Cartesian Therapeutics Inc and owns about 9,368,388 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $186 Million. Besides these, Timothy A Springer also holds Scholar Rock Holding Corp (SRRK) . Details can be seen in Timothy A Springer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy A Springer has not made any transactions after 2024-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy A Springer
Timothy A Springer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy A Springer owns 3 companies in total, including Cartesian Therapeutics Inc (RNAC) , Morphic Holding Inc (MORF) , and Scholar Rock Holding Corp (SRRK) .
Click here to see the complete history of Timothy A Springer’s form 4 insider trades.
Insider Ownership Summary of Timothy A Springer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2024-11-18 | director |
| MORF | Morphic Holding Inc | 2023-05-03 | director & 10 percent owner |
| SRRK | Scholar Rock Holding Corp | 2019-09-03 | 10 percent owner |
Timothy A Springer Latest Holdings Summary
Timothy A Springer currently owns a total of 4 stocks. Among these stocks, Timothy A Springer owns 7,418,960 shares of Morphic Holding Inc (MORF) as of May 3, 2023, with a value of $423 Million and a weighting of 42.01%. Timothy A Springer owns 4,593,121 shares of Tectonic Therapeutic Inc (TECX) as of October 22, 2024, with a value of $235 Million and a weighting of 23.36%. Timothy A Springer also owns 9,368,388 shares of Cartesian Therapeutics Inc (RNAC) as of December 23, 2024, with a value of $186 Million and a weighting of 18.5%. The other 1 stocks Scholar Rock Holding Corp (SRRK) have a combined weighting of 16.13% among all his current holdings.
Latest Holdings of Timothy A Springer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MORF | Morphic Holding Inc | 2023-05-03 | 7,418,960 | 56.99 | 422,806,530 |
| TECX | Tectonic Therapeutic Inc | 2024-10-22 | 4,593,121 | 51.20 | 235,167,795 |
| RNAC | Cartesian Therapeutics Inc | 2024-12-23 | 9,368,388 | 19.88 | 186,243,553 |
| SRRK | Scholar Rock Holding Corp | 2018-05-29 | 3,549,422 | 45.73 | 162,315,068 |
Holding Weightings of Timothy A Springer
Timothy A Springer Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy A Springer has made a total of 4 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Morphic Holding Inc is the acquisition of 1,050,000 shares on May 3, 2023, which cost Timothy A Springer around $47 Million.
According to the SEC Form 4 filings, Timothy A Springer has made a total of 2 transactions in Tectonic Therapeutic Inc (TECX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Tectonic Therapeutic Inc is the acquisition of 300,000 shares on October 22, 2024, which cost Timothy A Springer around $10 Million.
According to the SEC Form 4 filings, Timothy A Springer has made a total of 14 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 14 buys and 0 sells. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 52,189 shares on December 23, 2024, which cost Timothy A Springer around $964,975.
More details on Timothy A Springer's insider transactions can be found in the Insider Trading History of Timothy A Springer table.Insider Trading History of Timothy A Springer
- 1
Timothy A Springer Trading Performance
GuruFocus tracks the stock performance after each of Timothy A Springer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy A Springer is 14.35%. GuruFocus also compares Timothy A Springer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy A Springer within 3 months outperforms 16 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy A Springer's insider trading performs compared to the benchmark.
Performance of Timothy A Springer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.53 | | | | | |
| Relative Return to S&P 500(%) | 12.95 | | | | | |
Timothy A Springer Ownership Network
Timothy A Springer Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Timothy A Springer is the director of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Timothy A Springer made 7 insider transaction in Cartesian Therapeutics Inc (RNAC) with a net purchase of 1,921,182. Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net sale of 52,115 shares made by , a net purchase of 7,500 shares made by Timothy C Barabe , and a net sale of 2,932 shares made by Carsten Brunn .
In summary, during the past 3 months, insiders sold 241,836 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 689,850 shares, with a net purchase of 448,014 shares. During the past 18 months, 241,957 shares of Cartesian Therapeutics Inc (RNAC) were sold and 746,143 shares were bought by its insiders, resulting in a net purchase of 504,186 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Timothy A Springer Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy A Springer. You might contact Timothy A Springer via mailing address: 36 Woodman Road, Chestnut Hill Ma 02467.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
